Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
Luxembourg is a small European country with a population of approximately 626,000 people. Despite its size, Luxembourg has a well-developed pharmaceutical market that is constantly evolving.
Customer preferences: The pharmaceutical market in Luxembourg is primarily driven by the demand for prescription drugs and over-the-counter medications. There is also a growing interest in natural and alternative medicine, as consumers become more health-conscious. Additionally, the aging population in Luxembourg is contributing to the demand for pharmaceutical products, as they require more healthcare services.
Trends in the market: One of the major trends in the Luxembourg pharmaceutical market is the increasing use of e-prescriptions. This is due to the government's initiative to digitize the healthcare system, which has led to a more efficient and streamlined process for prescribing and dispensing medication. Another trend is the growing demand for personalized medicine, which tailors treatments to an individual's genetic makeup. This approach is gaining popularity in Luxembourg, as it is more effective and efficient than traditional treatments.
Local special circumstances: Luxembourg has a highly developed healthcare system, which is accessible to all residents. The government heavily regulates the pharmaceutical market, which ensures the safety and efficacy of medications. Additionally, Luxembourg is home to many pharmaceutical companies, which contributes to the growth and development of the market.
Underlying macroeconomic factors: The pharmaceutical market in Luxembourg is influenced by several macroeconomic factors, including the country's GDP and healthcare spending. The high GDP per capita in Luxembourg means that residents have more disposable income to spend on healthcare, including pharmaceutical products. Additionally, the government's commitment to investing in healthcare has led to increased spending on pharmaceuticals, which has contributed to the growth of the market. Overall, the pharmaceutical market in Luxembourg is expected to continue to grow and evolve, as the demand for healthcare services and products increases.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)